F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine. - John,GW.; Pauwels,PJ.; Perez,M.; Halazy,S.; LeGrand,B.; Verscheure,Y.; Valentin,JP.; Palmier,C.; Wurch,T.; Chopin,P.; Marien,M.; Kleven,MS.; et al. (Pharmacol Exp Ther, 1999)